Hepatitis C Trial, Recruiting (NCT07667101)

Hepatitis C Trial, Recruiting NCT07667101 Sponsor: University of Washington Condition: Hepatitis C

Printed from Voxsanity (voxsanity.com.au) — NCT07667101 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis C

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are currently living in one of DESC's Permanent Supportive Housing (PSH) buildings when you sign up for the study
You have had a positive test result for Hepatitis C (HCV), either an antibody test or a test measuring the virus in your blood
You are willing to give permission for the research team to access your pharmacy and/or other Hepatitis C treatment provider records during the study period (from your first visit to your 24-month visit)

Who may not be able to join:

You are already taking medication to treat Hepatitis C when the study begins
You have a cognitive or mental condition (short-term or long-term) that makes it difficult to fully understand and agree to take part in the study
You are currently in jail or prison, or are expected to be incarcerated soon
You are planning to move away from the Seattle area within the next 24 months
You do not speak English
Your behaviour raises safety concerns, as judged by the research staff (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Judith Tsui, MD, MPH, University of Washington

Phone: 206-744-1838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07667101

Sponsor: University of Washington

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis C

Trial contact: 206-744-1838

More information: https://clinicaltrials.gov/study/NCT07667101

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are currently living in one of DESC's Permanent Supportive Housing (PSH) buildings when you sign up for the study
You have had a positive test result for Hepatitis C (HCV), either an antibody test or a test measuring the virus in your blood
You are willing to give permission for the research team to access your pharmacy and/or other Hepatitis C treatment provider records during the study period (from your first visit to your 24-month visit)

Who may not be able to join:

You are already taking medication to treat Hepatitis C when the study begins
You have a cognitive or mental condition (short-term or long-term) that makes it difficult to fully understand and agree to take part in the study
You are currently in jail or prison, or are expected to be incarcerated soon
You are planning to move away from the Seattle area within the next 24 months
You do not speak English
Your behaviour raises safety concerns, as judged by the research staff (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Washington

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

HCV Evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov